Short answer
Omada Health, Inc. (OMDA) filed its Q3 2026 10-Q quarterly report on Nov 6, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $91M (up 34.2% year over year) with net income of $7M.
Q3 2026 key financials · XBRL
- Revenue
- $91M
- +34.2% YoY · +4.0% QoQ
- Net income
- $7M
- +306.1% YoY · +23.7% QoQ
- Operating margin
- 5.3%
- Gross margin
- 75.9%
- EPS (diluted)
- $0.10
- −73.0% YoY · +11.1% QoQ
Source: XBRL data from the Omada Health, Inc. (OMDA) Q3 2026 10-Q on SEC EDGAR. USD.
Omada Health, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $91.3M, up 34% YoY from $68.0M, driven by services revenue of $85.1M, up 35%
- Gross margin increased 10 percentage points YoY, with gross profit $69.3M versus $45.1M
- Services best-performing line, up $22.2M YoY; hardware revenue $6.2M, up 22% to $5.1M
- Nine-month operating cash flow $7.3M versus $(3.1)M, with $4.9M invested in software and equipment
- Cash and equivalents $243.2M; tariff-related device costs and rising GLP-1 affordability pressures remain headwinds
Risk Factors
- Newly added AI risk: December 2025 Executive Order and March 2026 framework create uncertainty over state-law preemption and compliance costs
- Regulatory risk: evolving AI requirements may force platform redesign, increase expenses, and trigger claims or enforcement
- Competitive risk: AI-native healthcare offerings may deliver care at lower operating cost and reduce demand for Omada programs
- Customer concentration: top five health plan and PBM partners generated 78% of nine-month 2026 revenue, including Cigna affiliates
- Financial risk: accumulated deficit reached $447.9 million as of September 30, 2026 despite nine-month net income of $8.9 million
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Omada Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.